DSM-5’s Bereavement Bind: Time for an Independent Review
April 6th 2012Opponents in the now well-worn, “Bereavement Exclusion” debate can probably agree on one thing: of all the proposed changes in the DSM-5, the move to eliminate the bereavement exclusion has ignited the most intense emotional reaction among the general public.
Does Evidence-Based Medicine Discourage Richer Assessment of Psychopathology and Treatment?
April 5th 2012The paradigm for modern psychiatry is evidence-based medicine (EBM)-it represents proven treatments for defined diagnoses. But there are major problems with this position, starting with the fact that while they are superior to placebo, evidence-based treatments too often are ineffective.
Introduction: Strategies for Treatment
April 3rd 2012When thinking about recent advances in psychopharmacology, we often point to new molecules with similar mechanisms of action but with better safety and tolerability profiles, or to molecules with novel mechanisms that effect positive change greater than that with existing treatments.
A Turning Point For DSM-5: Will the APA Trustees Finally Step to the Plate?
March 22nd 2012Up until now, the leadership of the American Psychiatric Association has stubbornly defended the indefensible DSM-5 proposal that would turn normal grief into clinical depression. APA has blithely ignored the contrary scientific evidence